Clinical Trials Browser

Interventional × Breast Cancer Metastatic × fluzoparib × Clear all

NCT05759546 2024-02-06

PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer

Phase 2 Recruiting

Breast Cancer Metastatic